121 results
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
to the U.S. Food and Drug Administration (“FDA”) and its Accelerate Arc product, Wave instrument and Positive Blood Culture (PBC) Gram Negative assay … and lab wallet-share by offering both Positive Blood Culture (PBC) and Isolated Colony (Isolates) on single instrument Lowered overall debt and extended
CORRESP
AXDX
Accelerate Diagnostics Inc
9 Sep 14
Correspondence with SEC
12:00am
for all types of pathogens within our identification panel. The exact regulatory path for the AST portion of our system and positive blood culture … that your system uses a “culture-free process.” Please tell us and in future filings disclose how you achieve cell growth without a culture. We note
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
27 Nov 23
Other Events
9:15am
together to bring rapid, automated microbial identification directly from positive blood culture samples
Tucson, Ariz. (November 27, 2023) – Accelerate … enables both companies to validate the use of Accelerate Diagnostics’ Arc™ system, an innovative, automated positive blood culture sample preparation
8-K
EX-99.2
AXDX
Accelerate Diagnostics Inc
13 Jan 22
Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results
9:16am
FASTER 13
The Solution: Two ways to win with Pheno depending on customer workflow preferences Blood Culture Systems Bactec Œ Virtuo ® Positive Blood … Culture Gram Stain Molecular Identification Biomerieux BioFire ® Roche ePLEX ® Diasorin Verigene ® Rapid Susceptibility Accelerate PhenoTest
CORRESP
AXDX
Accelerate Diagnostics Inc
24 Oct 14
Correspondence with SEC
12:00am
submission for the integrated Accelerate ID/AST System and a positive blood culture multi-parameter test panel. This panel will cover over 80 … filings:
After FDA approval of the Company’s initial positive blood culture multi-parameter test panel, additions to that panel and/or new test
8-K
EX-99.1
1ls2znjt14tlc qa087
22 Jun 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
epkge4o
13 Jul 16
Accelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit
12:00am
8-K
EX-99.1
zuwsj6 9xcgu
21 Jan 10
Regulation FD Disclosure
12:00am
8-K
i753xkfikf1ks9
21 Oct 22
Other Events
4:02pm
8-K
EX-99.1
vrdlsrcq0m74b4lwt
8 Jan 24
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
6:03am
8-K
EX-99.2
yj5wl
6 Nov 20
Accelerate Diagnostics Reports Second Quarter 2020 Financial Results & Announces New Product Offering
11:59am
8-K
EX-99.2
afy46mtb2i6x3h1xnjb
29 Mar 24
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
5:19pm
8-K
EX-99.1
hr8ry p3rob644
14 May 18
Accelerate Diagnostics reports Q1 2018 financial results
5:29pm
8-K
EX-99.1
n3o 9uvdovsxk
6 Nov 18
Accelerate Diagnostics reports Q3 2018 financial results
4:05pm
8-K
EX-99.1
no1cyif8s64hn
16 May 22
Accelerate Diagnostics Reports First Quarter 2022 Financial Results
4:15pm
8-K
EX-99.1
l9dzsbphrly4k u6ne
13 Dec 12
Accelr8 Announces NASDAQ Capital Market Listing
12:00am
8-K
EX-99.1
bq01t08i
8 May 24
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
4:31pm